4512 — Wakamoto Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Wakamoto Pharmaceutical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3,232	3,879	3,665	2,955	2,006
Net Total Accounts Receivable
Net Total Receivables	2,811	3,214	2,875	2,627	3,522
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8,608	9,353	8,970	8,908	9,672
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,297	3,032	3,028	3,313	3,662
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	14,953	15,712	15,421	15,003	16,500
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,009	2,239	1,808	2,035	2,781
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	3,473	3,805	3,395	3,392	4,491
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	11,481	11,907	12,026	11,610	12,009
Total Liabilities & Shareholders' Equity	14,953	15,712	15,421	15,003	16,500
Total Common Shares Outstanding